Pediatric drug development offers advantages to younger patients through the availability of newly developed medicine forms as well as advantages to the sponsor pharmaceutical companies through extended exclusivity for their marketed product.

This webinar will:

• Provide an overview of the pediatric market and discuss potential growth areas
• Consider the challenges and opportunities of pediatric formulations
• Review several pediatric formulation dosage forms including liquid dosage forms and solid dosage forms (mini-tablets, orodispersible tablets (ODT) and chewable formulation)
• Conclude with an overview of the regulatory considerations for new pediatric formulations